<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Reddy</surname>
    <given-names>K. R.</given-names>
   </name>
   <name>
    <surname>Wright</surname>
    <given-names>T. L.</given-names>
   </name>
   <name>
    <surname>Pockros</surname>
    <given-names>P. J.</given-names>
   </name>
   <name>
    <surname>Shiffman</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Everson</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Reindollar</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2001</year>). 
  <article-title>Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C</article-title>. 
  <source>Hepatology</source>
  <volume>33</volume>, 
  <fpage>433</fpage>â€“
  <lpage>438</lpage>. 
  <pub-id pub-id-type="doi">10.1053/jhep.2001.21747</pub-id>
  <?supplied-pmid 11172346?>
  <pub-id pub-id-type="pmid">11172346</pub-id>
 </mixed-citation>
</ref>
